Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price was up 0.8% during trading on Thursday . The stock traded as high as $2.51 and last traded at $2.50. Approximately 16,859,926 shares traded hands during mid-day trading, a decline of 33% from the average daily volume of 25,174,572 shares. The stock had previously closed at $2.48.
Tilray Trading Down 0.4 %
The firm has a market cap of $1.83 billion, a price-to-earnings ratio of -1.13 and a beta of 2.30. The company has a 50-day moving average price of $1.87 and a 200 day moving average price of $2.00. The company has a quick ratio of 0.99, a current ratio of 1.63 and a debt-to-equity ratio of 0.11.
Insider Activity at Tilray
In other news, CEO Irwin D. Simon acquired 53,700 shares of Tilray stock in a transaction that occurred on Friday, January 12th. The stock was purchased at an average price of $1.88 per share, with a total value of $100,956.00. Following the completion of the transaction, the chief executive officer now owns 2,033,058 shares in the company, valued at $3,822,149.04. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CEO Irwin D. Simon acquired 53,700 shares of Tilray stock in a transaction that occurred on Friday, January 12th. The stock was purchased at an average price of $1.88 per share, with a total value of $100,956.00. Following the completion of the transaction, the chief executive officer now owns 2,033,058 shares in the company, valued at $3,822,149.04. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Carl A. Merton acquired 20,000 shares of Tilray stock in a transaction that occurred on Friday, January 12th. The shares were purchased at an average cost of $1.87 per share, with a total value of $37,400.00. Following the transaction, the chief financial officer now owns 20,000 shares of the company’s stock, valued at approximately $37,400. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 96,300 shares of company stock valued at $183,210. Insiders own 0.68% of the company’s stock.
Hedge Funds Weigh In On Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Stories
- Five stocks we like better than Tilray
- Investing In Preferred Stock vs. Common Stock
- 3 Value Stocks Too Small For Buffett’s Portfolio
- How to Use Stock Screeners to Find Stocks
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What Are Dividend Challengers?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.